Literature DB >> 20838390

Post-transplantation cyclophosphamide for GVHD prophylaxis in severe aplastic anemia.

A E Dezern, L Luznik, E J Fuchs, R J Jones, R A Brodsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20838390      PMCID： PMC4161041          DOI： 10.1038/bmt.2010.213

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  12 in total

1.  Current results of bone marrow transplantation in patients with acquired severe aplastic anemia. Report of the European Group for Blood and Marrow transplantation. On behalf of the Working Party on Severe Aplastic Anemia of the European Group for Blood and Marrow Transplantation.

Authors:  A Bacigalupo; R Oneto; B Bruno; G Socié; J Passweg; A Locasciulli; M T Van Lint; A Tichelli; S McCann; J Marsh; P Ljungman; J Hows; P Marin; H Schrezenmeier
Journal:  Acta Haematol       Date:  2000       Impact factor: 2.195

Review 2.  Aplastic anaemia.

Authors:  Robert A Brodsky; Richard J Jones
Journal:  Lancet       Date:  2005 May 7-13       Impact factor: 79.321

Review 3.  Current status of allogeneic bone marrow transplantation in acquired aplastic anemia.

Authors:  M M Horowitz
Journal:  Semin Hematol       Date:  2000-01       Impact factor: 3.851

Review 4.  Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience.

Authors:  A Bacigalupo; R Brand; R Oneto; B Bruno; G Socié; J Passweg; A Locasciulli; M T Van Lint; A Tichelli; S McCann; J Marsh; P Ljungman; J Hows; P Marin; H Schrezenmeier
Journal:  Semin Hematol       Date:  2000-01       Impact factor: 3.851

5.  Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.

Authors:  K Doney; W Leisenring; R Storb; F R Appelbaum
Journal:  Ann Intern Med       Date:  1997-01-15       Impact factor: 25.391

6.  Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy.

Authors:  H J Deeg; K Seidel; J Casper; C Anasetti; S Davies; J L Gajeweski; M Territo; N Ramsay; R E Harris; H Catro-Malaspina; R Collins; R Champlin; G Schoch; R King; C Howe
Journal:  Biol Blood Marrow Transplant       Date:  1999       Impact factor: 5.742

7.  Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases.

Authors:  R A Brodsky; L Luznik; J Bolaños-Meade; M S Leffell; R J Jones; E J Fuchs
Journal:  Bone Marrow Transplant       Date:  2008-07-14       Impact factor: 5.483

8.  HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.

Authors:  Leo Luznik; Paul V O'Donnell; Heather J Symons; Allen R Chen; M Susan Leffell; Marianna Zahurak; Ted A Gooley; Steve Piantadosi; Michele Kaup; Richard F Ambinder; Carol Ann Huff; William Matsui; Javier Bolaños-Meade; Ivan Borrello; Jonathan D Powell; Elizabeth Harrington; Sandy Warnock; Mary Flowers; Robert A Brodsky; Brenda M Sandmaier; Rainer F Storb; Richard J Jones; Ephraim J Fuchs
Journal:  Biol Blood Marrow Transplant       Date:  2008-06       Impact factor: 5.742

Review 9.  Unrelated donor stem cell transplantation in acquired severe aplastic anemia: a systematic review.

Authors:  Frank Peinemann; Ulrich Grouven; Nicolaus Kröger; Max Pittler; Beate Zschorlich; Stefan Lange
Journal:  Haematologica       Date:  2009-07-31       Impact factor: 9.941

Review 10.  High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation.

Authors:  Leo Luznik; Ephraim J Fuchs
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829
View more
  14 in total

Review 1.  Clinical management of aplastic anemia.

Authors:  Amy E Dezern; Robert A Brodsky
Journal:  Expert Rev Hematol       Date:  2011-04       Impact factor: 2.929

2.  Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide.

Authors:  Amy E DeZern; Marianna L Zahurak; Heather J Symons; Kenneth R Cooke; Gary L Rosner; Douglas E Gladstone; Carol Ann Huff; Lode J Swinnen; Philip Imus; Ivan Borrello; Nina Wagner-Johnston; Richard F Ambinder; Leo Luznik; Javier Bolaños-Meade; Ephraim J Fuchs; Richard J Jones; Robert A Brodsky
Journal:  Blood Adv       Date:  2020-04-28

3.  Alternative Donor Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Refractory Severe Aplastic Anemia.

Authors:  Amy E DeZern; Marianna Zahurak; Heather Symons; Kenneth Cooke; Richard J Jones; Robert A Brodsky
Journal:  Biol Blood Marrow Transplant       Date:  2016-12-21       Impact factor: 5.742

4.  Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study.

Authors:  I Esteves; C Bonfim; R Pasquini; V Funke; N F Pereira; V Rocha; Y Novis; C Arrais; V Colturato; M P de Souza; M Torres; J F Fernandes; F R Kerbauy; A A F Ribeiro; F P S Santos; N Hamerschlak
Journal:  Bone Marrow Transplant       Date:  2015-03-02       Impact factor: 5.483

Review 5.  Transplantation for bone marrow failure: current issues.

Authors:  Régis Peffault de Latour
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

6.  Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial.

Authors:  Amy E DeZern; Mary Eapen; Juan Wu; Julie-An Talano; Melhem Solh; Blachy J Dávila Saldaña; Chatchada Karanes; Mitchell E Horwitz; Kanwaldeep Mallhi; Sally Arai; Nosha Farhadfar; Elizabeth Hexner; Peter Westervelt; Joseph H Antin; H Joachim Deeg; Eric Leifer; Robert A Brodsky; Brent R Logan; Mary M Horowitz; Richard J Jones; Michael A Pulsipher
Journal:  Lancet Haematol       Date:  2022-07-27       Impact factor: 30.153

7.  High-dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia.

Authors:  Christopher J Gamper; Clifford M Takemoto; Allen R Chen; Heather J Symons; David M Loeb; James F Casella; Amy E Dezern; Karen E King; Andrea M McGonigle; Richard J Jones; Robert A Brodsky
Journal:  J Pediatr Hematol Oncol       Date:  2016-11       Impact factor: 1.289

Review 8.  Haploidentical Donor Bone Marrow Transplantation for Severe Aplastic Anemia.

Authors:  Amy E DeZern; Robert A Brodsky
Journal:  Hematol Oncol Clin North Am       Date:  2018-05-28       Impact factor: 3.722

Review 9.  Recent advances in treatment of aplastic anemia.

Authors:  Seung Hwan Shin; Sung Eun Lee; Jong Wook Lee
Journal:  Korean J Intern Med       Date:  2014-10-31       Impact factor: 2.884

10.  Stem cell donors should be screened for CHIP.

Authors:  Amy E DeZern; Lukasz P Gondek
Journal:  Blood Adv       Date:  2020-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.